Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-29 Purchase | 2026-07-31 5:13 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 45,768 | $9.9573 | $455,726 | 18,489,293 (Indirect) | View |
| 2026-07-24 Purchase | 2026-07-28 5:24 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 41,319 | $9.99 | $412,777 | 18,443,525 (Indirect) | View |
| 2026-07-21 Purchase | 2026-07-23 9:22 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 264,586 | $9.7636 | $2,583,314 | 18,402,206 (Indirect) | View |
| 2026-07-13 Purchase(A) | 2026-07-23 9:21 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 6,522 | $8.94 | $58,307 | 16,817,543 (Indirect) | View |
| 2026-07-16 Purchase | 2026-07-20 6:08 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 160,354 | $8.931 | $1,432,119 | 18,137,650 (Indirect) | View |
| 2026-07-10 Purchase | 2026-07-14 7:00 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 21,654 | $8.9609 | $194,040 | 17,977,296 (Indirect) | View |
| 2026-06-25 Purchase | 2026-06-29 4:20 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 32,876 | $8.8857 | $292,126 | 17,955,642 (Indirect) | View |
| 2026-06-12 Purchase | 2026-06-16 6:08 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 531,326 | $8.6574 | $4,599,903 | 17,922,766 (Indirect) | View |
| 2026-06-09 Purchase | 2026-06-11 7:36 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,027,722 | $7.4438 | $7,650,148 | 17,391,440 (Indirect) | View |
| 2026-05-11 Purchase | 2026-05-28 4:34 pm | Artiva Biotherapeutics Inc. | ARTV | GC Corp. GC Cell Corp 10% Owner | 1,432,291 | $11.52 | $16,499,992 | 5,999,703 (Indirect Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:52 pm | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 3,095 | $9.0078 | $27,879 | 148,228 (Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:52 pm | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 7,002 | $9.0078 | $63,073 | 293,450 (Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:51 pm | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Compliance Officer | 8,790 | $9.0078 | $79,179 | 337,920 (Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:50 pm | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 7,037 | $9.0076 | $63,386 | 144,963 (Direct) | View |
| 2026-05-19 Sale | 2026-05-19 9:50 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred Chief Executive Officer | 27,116 | $9.0077 | $244,253 | 1,535,082 (Direct) | View |
| 2026-05-11 Purchase | 2026-05-13 5:45 pm | Artiva Biotherapeutics Inc. | ARTV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 6,510,416 | $11.52 | $74,999,992 | 18,533,856 (Indirect) | View |
| 2025-12-15 Sale | 2025-12-15 9:19 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 3,187 | $6 | $19,122 | 1,209,948 (Direct) | View |
| 2025-11-17 Sale | 2025-11-17 8:37 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 6,375 | $3.376 | $21,522 | 343,999 (Direct) | View |
| 2025-10-17 Sale | 2025-10-17 8:44 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 25,500 | $6 | $153,000 | 356,721 (Direct) | View |
| 2025-08-15 Sale | 2025-08-18 8:15 pm | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 25,500 | $2.7286 | $69,579 | 382,221 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-18 Option Award | 2026-05-19 08:11 am | N/A 2036-05-17 | Artiva Biotherapeutics Inc. | ARTV | Miralles Gines Diego President & Head of R&D | 310,000 | $0 | 310,000 (Direct) | View |
| 2026-03-10 Option Award | 2026-03-10 4:47 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Huston Thad Allen Chief Financial Officer | 220,000 | $0 | 220,000 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-19 9:50 pm | N/A 2036-02-17 | Artiva Biotherapeutics Inc. | ARTV | Sorg Elaine K. Director | 27,500 | $0 | 27,500 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 6:51 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 1,521 | $4 | 151,323 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 6:51 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 46,000 | $0 | 151,323 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 6:50 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 2,187 | $4 | 300,452 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 6:50 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 117,300 | $0 | 300,452 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 6:49 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 3,515 | $4 | 346,710 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 6:49 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 117,300 | $0 | 346,710 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 6:48 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Banerjee Subhashis Chief Medical Officer | 102,000 | $0 | 152,000 (Direct) | View |
| 2026-02-15 Tax Withholding | 2026-02-18 6:48 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 14,600 | $4 | 1,562,198 (Direct) | View |
| 2026-02-15 Option Award | 2026-02-18 6:48 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 366,850 | $0 | 1,562,198 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-12 7:21 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 67,253 | $0 | 106,844 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-12 7:20 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 107,156 | $0 | 185,339 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-12 7:19 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 84,877 | $0 | 232,925 (Direct) | View |
| 2025-12-12 Option Award | 2025-12-12 7:19 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 869,136 | $0 | 1,213,135 (Direct) | View |
| 2025-11-15 Tax Withholding | 2025-11-17 8:39 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 1,375 | $3.25 | 39,591 (Direct) | View |
| 2025-11-15 Tax Withholding | 2025-11-17 8:39 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Horan Christopher Chief Tech Operations Officer | 1,899 | $3.25 | 78,183 (Direct) | View |
| 2025-11-15 Tax Withholding | 2025-11-17 8:38 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Bush Jennifer COO, CLO, Secy, Compliance Off | 3,055 | $3.25 | 148,048 (Direct) | View |
| 2025-11-15 Tax Withholding | 2025-11-17 8:38 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer | 3,490 | $3.25 | 99,356 (Direct) | View |
| 2025-11-15 Tax Withholding | 2025-11-17 8:37 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 6,347 | $3.25 | 343,999 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 4,472 | $2.75 | 382,221 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Aslan Fred President and CEO | 4,472 | $2.13 | 382,221 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 1,639 | $2.75 | 40,966 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Raymon Heather SVP, Research and Development | 745 | $2.13 | 40,966 (Direct) | View |
| 2025-08-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer | 5,813 | $2.75 | 102,846 (Direct) | View |
| 2025-05-15 Tax Withholding | 2025-08-18 8:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | Krishnamohan Neha Chief Financial Officer | 1,341 | $2.13 | 102,846 (Direct) | View |